Speaker Profile
M.D., CSO, Ochre Bio
Biography
Quin is an MD/PhD with few extra degrees in genomics, mathematics, and statistical/machine learning. He uses deep genomic phenotyping technologies to develop RNA therapies for chronic liver disease. He started his first liver genomics company 17 years ago, and was most recently Head of Cellular and Systems Genomics for Novo Nordisk before co-founding Ochre Bio. Ochre Bio is a series A company, with labs in Oxford, Taipei, and New York where they regenerate human livers not good enough for transplantation. Think farms of livers on machines being refurbished by direct RNA reprogramming, so that fewer patients die waiting for a new liver.
Session Abstract – PMWC 2022 Silicon Valley
- Hope or Hype? The Role of ML in Drug Discovery and Development (PANEL)
Session Chair: Ansuman Satpathy, Stanford University
- Marcel Hop, Genentech
- Mark Jacobstein, Immunai
- Stacie Calad-Thomson, BioSymetrics
- Andrea deSouza, Eli Lilly and Company - Advancing Research and Drug Discovery with UK Biobank
Session Chair: Asha Collins, DNAnexus
- Lucy Burkitt-Gray, UK Biobank
- Lisa McFerrin, AWS - Machine Learning for Novel Target Discovery: Unique Techniques Meet Unique Data
Session Chair: Alex Morgan, Khosla Ventures
- Lindsay Edwards, Relation Therapeutics
- Kristen Fortney, BioAge
- Quin Wills, Ochre Bio
- Joseph Rodgers, Fountain Therapeutics
- Calum MacRae, Atman Health - AI/ML in Clinical Trial Design, Patient Selection and Prediction of Outcomes (PANEL)
Session Chair: Peter Lipsky, Ampel Bio
- Nasim Eftekhari, City of Hope
- Mika Newton, xCures, Inc.
- William Oh, Sema4
- Treating Genetics as Data: Computable, Structured Results for Precision Medicine
- Peter DeVault, Epic - DeepConsensus: Sequence Transformers for Sequence Correction
- Andrew Carroll, Google - AI in Small Molecule Design and Screening (PANEL)
Session Chair: Petrina Kamya, Insilico Medicine
- Jim Edwards, Janssen
- Tommaso Mansi, Johnson & Johnson
- Martin Emanuel Bittner, Arctoris - PMWC 2022 Showcase
- Kevin Cho, Envisagenics, Inc.
- Poojitha Ojamies, Novartis
- Steve Harrison, Engine Biosciences
